Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Canaccord Genuity Downgrades Bioventus to Hold

Canaccord Genuity Downgrades Bioventus to Hold

Canaccord Genuity analyst Kyle Rose downgrades Bioventus (NASDAQ:BVS) from Buy to Hold.

November 9, 2022

1 minute read

Canaccord Genuity analyst Kyle Rose downgrades Bioventus (NASDAQ:BVS) from Buy to Hold.

These Analysts Slash Their Forecasts On Fortrea Holdings After Q1 Results

May 14, 9:24 AM

Fortrea Holdings Inc. (NASDAQ:FTRE) reported soft first-quarter FY24 results and cut its revenue outlook on Monday. Revenue of…

January 5, 4:59 PM

Needham analyst Quinn Bolton maintained Mobileye Global Inc (NASDAQ: MBLY) with a Buy and lowered the

November 28, 11:03 AM

A popular crypto analyst has pointed out a new price target for Bitcoin (CRYPTO: BTC), altcoins and s**t coins.

September 7, 11:09 AM

Dave & Buster's Entertainment Inc (NASDAQ: PLAY) reported weaker-than-expected second-quarter sales.